CIK: 1171005 - Address: C/o Arcutis Biotherapeutics, Inc., Suite 110, Westlake Village, CA 91361
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret414243475287436
P%wins1002510075506769

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/6/20 17:23
10/2/20
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilverstein JonathanCADTP12,40025.000496122902I
2/4/20 17:27
2/3/20
ARQTArcutis Biotherapeutics, Inc.DEHealthDrugPharmaceutical PreparationsSilverstein JonathanCADTP.d9,50117.000559999%606I
1/30/18 18:42
1/30/18
TORCRestorbio, Inc.DEHealthDrugPharmaceutical PreparationsSilverstein JonathanMADTP.d8,00015.000533124,830I
7/25/16 17:08
7/25/16
BOLDAudentes Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagSilverstein JonathanCADTP.d50015.00183314,802I1-1017-1
7/24/14 17:09
7/22/14
ROKARoka Bioscience, Inc.DEElectrLabEqLaboratory Analytical InstrumSilverstein JonathanNJDTP.d4,60012.00538330I00-136-22-62-67
11/20/13 19:31
11/20/13
RLYPRelypsa IncHealthDrugPharmaceutical PreparationsSilverstein JonathanNYDTP.d7,83411.001271289,942I52911723311280
10/16/12 18:02
10/16/12
ICPTIntercept Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsSilverstein JonathanNYDTP.d5,00015.006333182,151I1-1137361209
10/24/05 12:22
10/20/05
AVNAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsSilverstein JonathanCADP1,5002.65056669,341I
4/12/05 13:46
4/8/05
AVNAvanir PharmaceuticalsCAHealthDrugPharmaceutical PreparationsSilverstein JonathanCADP1,9802.200900118,775I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact